Education
About Us
Working with TipRanks
Follow Us
Seer (SEER)
NASDAQ:SEER
SEER Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.56 - $2.63
Previous CloseN/A
Volume76.55K
Average Volume (3M)271.05K
Market Cap
$119.56M
Enterprise Value-$73.94M
Total Cash (Recent Filing)$40.75M
Total Debt (Recent Filing)$25.96M
Price to Earnings (P/E)―
Beta1.45
Next Earnings
May 13, 2025EPS Estimate
-0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.39
Shares Outstanding55,737,064
10 Day Avg. Volume343,478
30 Day Avg. Volume271,046
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.98
Price to Cash Flow (P/CF)-2.50
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.62
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.48
Enterprise Value/Ebitda0.79
Forecast
1Y Price Target
$3.00Price Target Upside50.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Seer News
PremiumCompany Announcements
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook
PremiumCompany Announcements
Seer, Inc. Reports 2024 Earnings and 2025 Outlook
PremiumCompany Announcements
Seer, Inc. Reports Q3 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
Product DemandManagement provided positive commentary on customer demand trends including the momentum that's been built by strategic initiatives (STAC and SIP) and awareness from third party publications.
Service Revenue GrowthSeer, Inc. experienced strong traction from its STAC program as sample volumes increased and service revenue grew by 28%.
Strategic CollaborationsThe recent expansion of the commercial team and a new collaboration with TMO are expected to contribute to growth in the latter half of 2025.
Bears Say
Government Funding UncertaintyGovernment funding uncertainty is impacting Seer, Inc.'s revenue visibility for 2025, with 30% of the company's revenue coming from the academic and government end market.
NIH Funding RiskUncertain NIH funding is a risk, with significant sales to direct US government labs and US universities.
Product Revenue DeclineSeer, Inc. saw a decline in product revenue driven by a decrease in instrument sales due to pressure on capital expenditure budgets and longer sales cycles.
---
Ownership Overview
6.50% Insiders
8.36% Mutual Funds
24.87% Other Institutional Investors
55.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SEER FAQ
What was Seer’s price range in the past 12 months?
Seer lowest stock price was $1.56 and its highest was $2.63 in the past 12 months.
What is Seer’s market cap?
Seer’s market cap is $119.56M.
When is Seer’s upcoming earnings report date?
Seer’s upcoming earnings report date is May 13, 2025 which is in 29 days.
How were Seer’s earnings last quarter?
Seer released its earnings results on Feb 27, 2025. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.387 by $0.017.
Is Seer overvalued?
According to Wall Street analysts Seer’s price is currently Undervalued.
Does Seer pay dividends?
Seer does not currently pay dividends.
What is Seer’s EPS estimate?
Seer’s EPS estimate is -0.36.
How many shares outstanding does Seer have?
Seer has 55,737,064 shares outstanding.
What happened to Seer’s price movement after its last earnings report?
Seer reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.387. Following the earnings report the stock price went down -4.545%.
Which hedge fund is a major shareholder of Seer?
Currently, no hedge funds are holding shares in SEER
---
Seer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (50.00% Upside)
$3.00 (50.00% Upside)
Hedge Fund Trend
Decreased
By 274.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $25.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
15.60%
12-Months-Change
Fundamentals
Return on Equity
-23.91%
Trailing 12-Months
Asset Growth
-15.97%
Trailing 12-Months
Company Description
Seer
Seer, Inc. (SEER) is a biotechnology company focused on developing and commercializing novel solutions to analyze biological molecules. The company operates primarily in the life sciences sector and offers innovative proteomics technologies. Its flagship product is the Proteograph Product Suite, which is designed to facilitate comprehensive and high-throughput proteomic analysis, enabling researchers to gain deeper insights into the biology of diseases and health conditions.
---
SEER Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment with significant achievements in customer engagement, expansion, and innovation, counterbalanced by revenue decline, net loss, and macroeconomic challenges. The outlook for 2025 is optimistic with expectations of revenue growth and strategic partnerships, but financial pressures and market uncertainties persist.Read More>---
SEER Stock 12 Month Forecast
Average Price Target
$3.00
▲(50.00% Upside)
Technical Analysis
Best Analysts Covering SEER
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
-6.50%
reiterated a buy rating 2 months ago
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.50% per trade.
---